NOT Impressed with progress on the covid front as I get the feeling funding has become a key issue. But I'm liking the fact that a potential partner has been mentioned with the HIV work.
What will a partnership with likes of Gilead do to the share price and funding situation?
still a hold for me but we now know we could be months away at least company expenditure is relatively low.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-25
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $6.308K | 311.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1673695 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 93000 | 2 |
View Market Depth
| Last trade - 15.39pm 08/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |